日本語English简体中文 繁體中文

688266 Suzhou Zelgen Biopharmaceuticals Co., Ltd.泽璟制药Shanghai Stock Exchange

0 posts

Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266) at a glance

Code
688266
Company
Suzhou Zelgen Biopharmaceuticals Co., Ltd.
Local name
泽璟制药
Market
Shanghai Stock Exchange
Share price
CN¥73.89 -3.42 (-4.42%) Nov 20 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266) Stock Price HistoryNear a 52-week low

Suzhou Zelgen Biopharmaceuticals Co., Ltd. closed at CN¥73.89 on Nov 20, 2026, −27.2% over 1 month, −28.1% over 1 year.

2026-10-21 契約の締結 泽璟制药关于自愿披露与艾伯维就ZG006的全球战略合作与许可选择权协议收…2026-10-24 新薬・製品の承認 泽璟制药关于自愿披露注射用ZG005治疗一线肝癌的III期临床试验完成…2026-10-31 第3四半期報告 泽璟制药2026年第三季度报告2026-11-05 株主総会の招集 泽璟制药关于召开2026年第一次临时股东会的通知2026-11-12 株主総会 泽璟制药2026年第一次临时股东会会议资料2026-11-19 新薬・製品の承認 泽璟制药关于自愿披露ZG006治疗晚期小细胞肺癌患者的关键性临床试…CN¥103.81CN¥73.89Oct 20Nov 20
Price5-day MA25-day MASSE CompositeDisclosures
1-Month HighCN¥103.81Oct 26
1-Month LowCN¥73.89Nov 20
1-Week Change−13.1%vs Nov 13
1-Month Change−27.2%vs Oct 20

If you had invested CN¥10,000 1 month ago, it would be worth CN¥7,280 today (−27.2%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −5.4%, while this stock moved −27.2%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)CN¥73.89−3.42−4.42%
Nov 19 (Thu)CN¥77.31+0.21+0.27%
Nov 18 (Wed)CN¥77.10−2.42−3.04%
Nov 17 (Tue)CN¥79.52−3.66−4.40%
Nov 16 (Mon)CN¥83.18−1.87−2.20%
Nov 13 (Fri)CN¥85.05−2.56−2.92%
Nov 12 (Thu)CN¥87.61−0.98−1.11%
Nov 11 (Wed)CN¥88.59−1.01−1.13%
Nov 10 (Tue)CN¥89.60−0.61−0.68%
Nov 9 (Mon)CN¥90.21−0.59−0.65%
2026-10-14 上場・売買開始 泽璟制药关于自愿披露盐酸吉卡昔替尼片治疗活动性强直性脊柱炎的新药…2026-10-21 契約の締結 泽璟制药关于自愿披露与艾伯维就ZG006的全球战略合作与许可选择权协议收…2026-10-24 新薬・製品の承認 泽璟制药关于自愿披露注射用ZG005治疗一线肝癌的III期临床试验完成…2026-10-31 第3四半期報告 泽璟制药2026年第三季度报告2026-11-05 株主総会の招集 泽璟制药关于召开2026年第一次临时股东会的通知2026-11-12 株主総会 泽璟制药2026年第一次临时股东会会议资料2026-11-19 新薬・製品の承認 泽璟制药关于自愿披露ZG006治疗晚期小细胞肺癌患者的关键性临床试…CN¥138.34CN¥73.89Aug 20Nov 20
Price5-day MA25-day MASSE CompositeDisclosures
3-Month HighCN¥138.34Aug 20
3-Month LowCN¥73.89Nov 20
1-Month Change−27.2%vs Oct 20
3-Month Change−46.6%vs Aug 20

If you had invested CN¥10,000 3 months ago, it would be worth CN¥5,341 today (−46.6%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −9.5%, while this stock moved −46.6%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)CN¥73.89−3.42−4.42%
Nov 19 (Thu)CN¥77.31+0.21+0.27%
Nov 18 (Wed)CN¥77.10−2.42−3.04%
Nov 17 (Tue)CN¥79.52−3.66−4.40%
Nov 16 (Mon)CN¥83.18−1.87−2.20%
Nov 13 (Fri)CN¥85.05−2.56−2.92%
Nov 12 (Thu)CN¥87.61−0.98−1.11%
Nov 11 (Wed)CN¥88.59−1.01−1.13%
Nov 10 (Tue)CN¥89.60−0.61−0.68%
Nov 9 (Mon)CN¥90.21−0.59−0.65%
2026-10-14 上場・売買開始 泽璟制药关于自愿披露盐酸吉卡昔替尼片治疗活动性强直性脊柱炎的新药…2026-10-21 契約の締結 泽璟制药关于自愿披露与艾伯维就ZG006的全球战略合作与许可选择权协议收…2026-10-24 新薬・製品の承認 泽璟制药关于自愿披露注射用ZG005治疗一线肝癌的III期临床试验完成…2026-10-31 第3四半期報告 泽璟制药2026年第三季度报告2026-11-05 株主総会の招集 泽璟制药关于召开2026年第一次临时股东会的通知2026-11-12 株主総会 泽璟制药2026年第一次临时股东会会议资料2026-11-19 新薬・製品の承認 泽璟制药关于自愿披露ZG006治疗晚期小细胞肺癌患者的关键性临床试…CN¥147.40CN¥73.89May 20Nov 20
Price25-day MA75-day MASSE CompositeDisclosures
6-Month HighCN¥147.40Jul 14
6-Month LowCN¥73.89Nov 20
3-Month Change−46.6%vs Aug 20
6-Month Change−26.2%vs May 20

If you had invested CN¥10,000 6 months ago, it would be worth CN¥7,384 today (−26.2%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −15.1%, while this stock moved −26.2%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026CN¥73.89−9.4%
Oct 2026CN¥81.59−25.8%
Sep 2026CN¥110.00−6.5%
Aug 2026CN¥117.59−3.7%
Jul 2026CN¥122.10+4.7%
Jun 2026CN¥116.66+16.7%
May 2026CN¥99.93−3.9%
2026-10-14 上場・売買開始 泽璟制药关于自愿披露盐酸吉卡昔替尼片治疗活动性强直性脊柱炎的新药…2026-10-21 契約の締結 泽璟制药关于自愿披露与艾伯维就ZG006的全球战略合作与许可选择权协议收…2026-10-24 新薬・製品の承認 泽璟制药关于自愿披露注射用ZG005治疗一线肝癌的III期临床试验完成…2026-10-31 第3四半期報告 泽璟制药2026年第三季度报告2026-11-05 株主総会の招集 泽璟制药关于召开2026年第一次临时股东会的通知2026-11-12 株主総会 泽璟制药2026年第一次临时股东会会议资料2026-11-19 新薬・製品の承認 泽璟制药关于自愿披露ZG006治疗晚期小细胞肺癌患者的关键性临床试…CN¥147.40CN¥73.89Nov 20Nov 20
Price25-day MA75-day MASSE CompositeDisclosures
52-Week HighCN¥147.40Jul 14
52-Week LowCN¥73.89Nov 20
Year to Date−20.3%vs Dec 31
From 52-Week High−49.9%Jul 14

If you had invested CN¥10,000 1 year ago, it would be worth CN¥7,188 today (−28.1%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −10.1%, while this stock moved −28.1%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026CN¥73.89−9.4%
Oct 2026CN¥81.59−25.8%
Sep 2026CN¥110.00−6.5%
Aug 2026CN¥117.59−3.7%
Jul 2026CN¥122.10+4.7%
Jun 2026CN¥116.66+16.7%
May 2026CN¥99.93−3.9%
Apr 2026CN¥104.00+5.3%
Mar 2026CN¥98.80+20.3%
Feb 2026CN¥82.12−6.8%
Jan 2026CN¥88.12−4.9%
Dec 2025CN¥92.70−15.7%
Nov 2025CN¥110.00―
CN¥145.00CN¥37.83Nov 20, 2023Nov 20, 2026
Price13-week MA26-week MASSE Composite
3-Year HighCN¥145.00Jul 10, 2026
3-Year LowCN¥37.83Jan 29, 2024
Annualized Return+16.4%
Max Drawdown−49.0%

If you had invested CN¥10,000 3 years ago, it would be worth CN¥15,785 today (+57.9%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved +16.2%, while this stock moved +57.9%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)CN¥73.89−20.3%
2025CN¥92.70―
CN¥145.00CN¥26.01Nov 22, 2021Nov 20, 2026
Price13-week MA26-week MASSE Composite
5-Year HighCN¥145.00Jul 10, 2026
5-Year LowCN¥26.01Apr 25, 2022
Annualized Return+2.8%
Max Drawdown−59.6%

If you had invested CN¥10,000 5 years ago, it would be worth CN¥11,470 today (+14.7%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −0.9%, while this stock moved +14.7%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)CN¥73.89−20.3%
2025CN¥92.70―
CN¥145.00CN¥26.01Jan 20, 2020Nov 20, 2026
Price1-year MA2-year MASSE Composite
All-Time HighCN¥145.00Jul 2026
All-Time LowCN¥26.01Apr 2022
Total Change−0.9%vs Jan 2020
Annualized Return−0.1%

If you had invested CN¥10,000 in Jan 2020, it would be worth CN¥9,906 today (−0.9%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved +18.7%, while this stock moved −0.9%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)CN¥73.89−20.3%
2025CN¥92.70+50.5%
2024CN¥61.58+16.3%
2023CN¥52.94+27.0%
2022CN¥41.70−29.1%
2021CN¥58.80−9.1%
2020CN¥64.69―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Jan 2020). Please check the latest prices before trading.

Key features of Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266)

Position within Chemical Pharmaceuticals (159 companies)

PER34.4xAbove the industry median of 30.4x (No. 63 from the lowest)
PBR11.38xAbove the industry median of 2.05x (No. 153 from the lowest)
ROE-13.96%No. 135 in the industry (highest first); median 4.50%
Market capCN¥19.6 bnNo. 17 in the industry (largest first)

Ranks among A-shares in the same industry (Eastmoney's Shenwan level-2 classification, 128 industries). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest. ROE is from the latest annual results; dividend yield is the past year's dividends divided by the close (as of 11/20).

Price milestones

52-week highCN¥147.407/14
52-week lowCN¥73.8911/20
Current position0.0%Where the low is 0% and the high is 100% (close on 11/20: CN¥73.89)
Year to date-20.3%No. 47 of 157 in the industry (best first)
1 year-28.1%

Based on closing prices (excluding dividends).

Kabutaro's ranking history

Top 50 gainers1 timeLatest: 8/20 (No. 36 among A-shares)
Top 50 losers4 timesLatest: 8/3 (No. 8 among A-shares)

Gainers and losers are counted day by day from closing prices over the past year (ranked within A-shares and Hong Kong stocks separately). For A-shares, moves beyond the daily price limit (stock splits, first days after listing, etc.) are excluded.

Calculated as of 2026/11/20 18:31 JST. Updated every evening.

Recent announcements (CNINFO, in Chinese)

Filings from the past 12 months (10).

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No posts yet. Be the first to write something.

Write on the Suzhou Zelgen Biopharmaceuticals Co., Ltd. board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Chinese stocks in English

Chinese Stock Message Board: stocks available in English

Other boards in English